These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1835937)

  • 1. No acute effect of physiological insulin increase on dehydroepiandrosterone sulfate in women with obesity and/or polycystic ovarian disease.
    Buyalos RP; Bradley EL; Judd HL; Zacur HA; Azziz R
    Fertil Steril; 1991 Dec; 56(6):1179-82. PubMed ID: 1835937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome.
    Buyalos RP; Geffner ME; Azziz R; Judd HL
    Hum Reprod; 1997 Jun; 12(6):1138-41. PubMed ID: 9221990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome.
    Tropeano G; Lucisano A; Liberale I; Barini A; Vuolo IP; Martino G; Menini E; Dell'Acqua S
    J Clin Endocrinol Metab; 1994 Feb; 78(2):305-9. PubMed ID: 8106616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance and secretion in polycystic ovarian disease.
    Bruno B; Poccia G; Fabbrini A
    J Endocrinol Invest; 1985 Oct; 8(5):443-8. PubMed ID: 2934464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of physiologic hyperinsulinemia during an oral glucose tolerance test on the levels of dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) in healthy young adults born with low and with normal birth weight.
    Vásárhelyi B; Bencsik P; Treszl A; Bardóczy Z; Tulassay T; Szathmari M
    Endocr J; 2003 Dec; 50(6):689-95. PubMed ID: 14709839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between circulating androgens, obesity, and hyperinsulinemia on serum insulin-like growth factor binding protein-1 in the polycystic ovarian syndrome.
    Buyalos RP; Pekonen F; Halme JK; Judd HL; Rutanen EM
    Am J Obstet Gynecol; 1995 Mar; 172(3):932-9. PubMed ID: 7534449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of oral glucose-mediated versus intravenous hyperinsulinemia on circulating androgen levels in women.
    Fox JH; Licholai T; Green G; Dunaif A
    Fertil Steril; 1993 Dec; 60(6):994-1000. PubMed ID: 8243706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of glycemic variations on the regulation of androgen metabolism in obese women with polycystic ovary syndrome.
    Ludwig AK; Goharian LG; Dietze T; Tauchert S; Rudolf S; Diedrich K; Schweiger U; Oltmanns KM
    Fertil Steril; 2009 Jul; 92(1):271-6. PubMed ID: 18692843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for insulin resistance in nonobese patients with polycystic ovarian disease.
    Jialal I; Naiker P; Reddi K; Moodley J; Joubert SM
    J Clin Endocrinol Metab; 1987 May; 64(5):1066-9. PubMed ID: 2951393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose, insulin and C-peptide secretion in obese and non obese women with polycystic ovarian disease.
    Mahabeer S; Naidoo C; Joubert SM
    Diabetes Res; 1990 Jun; 14(2):79-82. PubMed ID: 2134217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.
    Dunaif A; Scott D; Finegood D; Quintana B; Whitcomb R
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3299-306. PubMed ID: 8784087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
    Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR
    J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
    Vermeulen A; Kaufman JM; Giagulli VA
    J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding.
    Schriock ED; Buffington CK; Hubert GD; Kurtz BR; Kitabchi AE; Buster JE; Givens JR
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1329-31. PubMed ID: 2967305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DHEA, DHEAS and PCOS.
    Goodarzi MO; Carmina E; Azziz R
    J Steroid Biochem Mol Biol; 2015 Jan; 145():213-25. PubMed ID: 25008465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.
    Silfen ME; Denburg MR; Manibo AM; Lobo RA; Jaffe R; Ferin M; Levine LS; Oberfield SE
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4682-8. PubMed ID: 14557441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.